AUS
NZ
UK
CA
USA
IND
Cobre Limited (ASX:CBE) has submitted an application to the ASX for the quotation of 911,026 new ordinary fully paid shares issued on 3 July 2026. These shares resulted from the exercise of options from three distinct series. Specifically, 173,077 CBEAQ options were converted at $0.078 each, 53,333 CBEO options at $0.066 each, and 684,616 CBEAR options at $0.098 each. This development reflects ongoing confidence from optionholders who converted their options into ordinary shares during a period spanning late June to early July 2026. Market participants will be monitoring for additional option exercises and any subsequent effects on Cobre's total issued capital as the company advances its exploration efforts.
Key Points
- Company: Cobre Limited (ASX:CBE)
- New ordinary fully paid shares to be quoted: 911,026, issued on 3 July 2026
- Options converted: 173,077 CBEAQ at $0.078; 53,333 CBEO at $0.066; 684,616 CBEAR at $0.098
- Exercise dates ranged from 22 June 2026 to 24 July 2026 across the three tranches
- New shares rank equally with existing ordinary shares from the issue date
- Investors should watch for further option conversions and updated issued capital figures as ASX processes pending forms
911,026 New Shares Issued Following Conversion of Three Cobre Option Series
Cobre Limited’s recent update confirms the quotation of 911,026 new ordinary fully paid shares on the ASX, resulting from the exercise of options across three separate series. The company lodged the application on 3 July 2026 under Appendix 2A of the ASX Listing Rules, detailing each option tranche’s conversion price, expiry, and timing to provide clarity on the source of the new shares.
The three series include CBEAQ options expiring 13 August 2027 with an exercise price of $0.078, CBEO options expiring 21 November 2028, and CBEAR options expiring 2 October 2026 with an exercise price of $0.098. The aggregate conversion of these options into ordinary shares represents a measured increase in Cobre’s share capital, with optionholders opting to convert within a relatively brief timeframe.
CBEAQ Options Exercised at $0.078 on 22 June 2026
The first tranche comprised 173,077 CBEAQ options, each exercisable at $0.078 and expiring 13 August 2027. All options in this tranche were exercised on 22 June 2026, with the resulting shares issued on 3 July 2026. The cash payment was made in Australian dollars at the stated exercise price.
These shares rank equally with existing ordinary shares from the issue date. The filing does not clarify whether this exercise exhausts all CBEAQ options outstanding, indicating potential for further conversions before expiry. The remaining balance of CBEAQ options was not disclosed.
CBEO Options Exercised at $0.066 Between 29 June and 2 July 2026
The second tranche involved 53,333 CBEO options, expiring 21 November 2028, exercised over two dates: 29 June and 2 July 2026. The exercise price was $0.066 per option, with shares issued on 3 July 2026.
Given the later expiry date, holders retain conversion rights for over two more years, potentially enabling future capital inflows. The new shares rank equally with existing ordinary shares. The announcement did not disclose the remaining CBEO option balance.
CBEAR Options Constitute Largest Conversion: 684,616 Shares Issued at $0.098
The largest tranche was the CBEAR series, with 684,616 options exercised at $0.098 each. These options expire on 2 October 2026. The exercise window spanned from 22 June to 24 July 2026, indicating ongoing conversion activity. Shares were issued on 3 July 2026.
Being closest to expiry, the CBEAR options saw the highest volume of conversions, likely due to the narrowing exercise window. These shares also rank equally with existing ordinary shares. The last exercise date noted postdates the announcement, suggesting further conversions may occur and updated totals could follow.
Estimated Cash Proceeds from Option Exercises
Each tranche generated cash proceeds in Australian dollars. Based on disclosed figures, the 173,077 CBEAQ options at $0.078 imply gross proceeds of approximately $13,500; the 53,333 CBEO options at $0.066 imply about $3,520; and the 684,616 CBEAR options at $0.098 imply roughly $67,092.
These estimates derive from exercise prices and option counts; the company did not report total cash proceeds separately. Combined, the three tranches suggest approximately $84,112 in gross proceeds, representing a modest cash inflow enhancing Cobre’s treasury without materially altering its financial position.
New Shares Rank Equally with Existing Ordinary Shares
All shares issued from these option exercises rank equally with Cobre’s existing ordinary shares from 3 July 2026. Holders have identical rights regarding dividends, voting, and capital distributions. There are no disclosed restrictions or escrow conditions differentiating these shares.
This standard equal ranking ensures certainty for new shareholders and the market. While the 911,026 new shares increase the total shares outstanding, the dilution is expected to be minor relative to Cobre’s overall issued capital. The company did not provide a post-quotation total issued capital figure, as ASX processing of concurrent forms may affect the final count.
Options Not Issued Under Employee Incentive Schemes
The filing clarifies that CBEO and CBEAR options were not issued under employee incentive schemes, which is relevant for regulatory and disclosure reasons. This suggests the options were likely granted through placements, rights issues, or other financing arrangements rather than employee compensation.
No further background on the issuance circumstances of the CBEAQ, CBEO, or CBEAR options was provided.
Potential for Additional Conversions Ahead of Option Expiry Dates
The CBEAR options expire on 2 October 2026, requiring holders to exercise remaining options soon or forfeit them. It is unclear if all CBEAR options have been converted, so further exercises and filings may occur before expiry.
The CBEAQ options expire in August 2027 and the CBEO options in November 2028, both offering extended periods for additional conversions. Future exercise activity will influence Cobre’s share count and cash position. Investors should monitor subsequent filings for updates on outstanding options and conversions.
Implications of Option Exercise Timing on Holder Sentiment
Optionholders’ decisions to exercise rather than let options lapse or sell them suggest a preference for converting into ordinary shares under current conditions. The significant CBEAR conversion volume, with an exercise price of $0.098 and expiry approaching in October 2026, indicates holders viewed conversion as favorable.
This analysis is based on general market principles; the announcement contains no management commentary on holder sentiment, share price targets, or operational outlook. The immediate share price impact was not evident from public information. Investors should consider this update alongside broader corporate disclosures.
Issued Capital Outlook After 3 July 2026 Quotation
Following the quotation of 911,026 new shares, Cobre’s total ordinary shares on issue will increase accordingly. However, the filing notes that issued capital figures are automatically generated and may not reflect the current total if other filings are pending.
For an accurate view of Cobre’s issued capital, investors should consult the company’s latest Appendix 3B or other capital structure disclosures after ASX processes all pending forms. The company did not provide a confirmed total shares figure in this announcement. Future option conversions, especially with the approaching CBEAR expiry, and operational updates will be key milestones for shareholders.
